Warren Averett Asset Management, LLC Gilead Sciences, Inc. Transaction History
Warren Averett Asset Management, LLC
- $5.05 Billion
- Q2 2024
A detailed history of Warren Averett Asset Management, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Warren Averett Asset Management, LLC holds 27,256 shares of GILD stock, worth $2.31 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
27,256
Previous 26,455
3.03%
Holding current value
$2.31 Million
Previous $1.94 Million
3.46%
% of portfolio
0.04%
Previous 0.05%
Shares
10 transactions
Others Institutions Holding GILD
# of Institutions
1,880Shares Held
1.02BCall Options Held
12MPut Options Held
8.96M-
Black Rock Inc. New York, NY121MShares$10.2 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$9.75 Billion0.15% of portfolio
-
Capital World Investors Los Angeles, CA76.2MShares$6.45 Billion0.88% of portfolio
-
Capital Research Global Investors Los Angeles, CA60.4MShares$5.11 Billion0.94% of portfolio
-
State Street Corp Boston, MA59.3MShares$5.02 Billion0.18% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $106B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...